What is Total Cholesterol?
Total cholesterol measures the combined amount of cholesterol travelling in your bloodstream across all lipoprotein particles — the LDL ('bad') and HDL ('good') fractions, plus a portion estimated from your triglycerides. In Europe it is usually reported in mmol/L; many international and US labs use mg/dL. The key thing to understand is that it is a single summed value, so the same total can mean very different things. A total of, say, 6 mmol/L driven mostly by a high, protective HDL is not the same risk picture as the identical total driven by a high LDL. That is why total cholesterol on its own is a blunt instrument — it is the starting point of a lipid panel, not the conclusion. Optimize measures total cholesterol as one component of the full lipid profile, so you always see it next to LDL, HDL, triglycerides, non-HDL cholesterol (total minus HDL), and — where available — ApoB and Lp(a), which is how it is meant to be read.
Why is Total Cholesterol relevant?
Total cholesterol earned its place because it was the first widely available cholesterol screen, and it remains the number most people remember from a GP visit ('my cholesterol is X'). At a population level it still tracks with cardiovascular risk, and a clearly elevated total is a reasonable prompt to look closer. But as a standalone risk marker it has been overtaken: what damages the artery wall is the burden of LDL and other ApoB-carrying particles, not the total figure that also includes protective HDL. This is why modern risk tools, including the SCORE2 model used in Dutch primary care, now estimate risk from non-HDL cholesterol (total minus HDL) rather than from total cholesterol or the old total/HDL ratio. As a general, lab-dependent reference, a total cholesterol below about 5.2 mmol/L (around 200 mg/dL) is commonly treated as desirable for the general population, with values of roughly 5.2–6.2 mmol/L (about 200–240 mg/dL) considered borderline and above roughly 6.2 mmol/L (240 mg/dL) considered high. These are population reference points, not a diagnosis, and the 'right' target depends heavily on your overall cardiovascular risk — someone with diabetes or existing heart disease is usually steered toward lower LDL and non-HDL targets than the general bands suggest. The value matters most as context: read together with LDL, HDL, triglycerides, non-HDL cholesterol, and ApoB, it helps build a risk picture. Read alone, it can both falsely reassure (normal total masking a poor particle profile) and falsely alarm (high total driven by high HDL).
Total Cholesterol high or low — what it means
Always interpret total cholesterol within the full lipid panel, never on its own. The first move is to break it down: is a high total being driven by LDL (the fraction that matters most for risk), by triglycerides, or simply by a high HDL? Non-HDL cholesterol (total minus HDL) and, where available, ApoB give a far better sense of risk than the total alone, because they capture all the atherogenic, ApoB-carrying particles; LDL remains the main treatment target. The total/HDL ratio is the familiar older summary, but Dutch and European guidelines have largely moved to non-HDL cholesterol for estimating risk. Trend beats any single reading. Total cholesterol drifts with diet in the days before a test, with weight change, alcohol, illness, and season, and it tends to rise gradually with age and around menopause. A falling total at stable HDL and triglycerides usually reflects genuine LDL reduction; a rising total deserves a breakdown before you draw conclusions. For a fair baseline, test under comparable conditions and don't over-read a one-off result — total cholesterol and non-HDL cholesterol do not strictly require fasting, though the triglyceride component is more reliable fasting. If the breakdown shows the elevation sits in LDL or non-HDL cholesterol, the established levers are well known: a diet lower in saturated fat with more fibre, unsaturated fats, and plant foods; regular activity; losing excess weight; not smoking; and, where risk warrants it, lipid-lowering medication such as a statin. A markedly high total — particularly with a strong family history of early heart disease — can point to a genetic cause like familial hypercholesterolaemia and is worth discussing with a clinician. A low total is usually not a concern in itself and often reflects a favourable profile or lipid-lowering treatment. Very low values occasionally accompany other conditions (such as liver disease, an overactive thyroid, malnutrition, or chronic illness), so an unexpectedly low result that doesn't fit your situation is best interpreted in context with a clinician rather than in isolation.
Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.
Read about our scientific approach →